Inhibitors of Adenosine Deaminase: Continued Studies of Structure-Activity Relationships in Analogues of Coformycin

Nucleosides, Nucleotides and Nucleic Acids

Volumn 23, Issue 1-2, 2004, Pages 263-271

  Reayi, Ayub ^a   Hosmane, Ramachandra S ^a,b  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

Author keywords

Adenosine deaminase; Coformycin analogues; Imidazotriazepines; Inhibitors; Ring expanded ("fat") purines

Indexed keywords

ADENOSINE DEAMINASE INHIBITOR; COFORMYCIN; IMIDAZOLE DERIVATIVE; IMIDAZOTRIAZEPINE; PURINE; TRIAZENE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL BINDING; CHEMICAL STRUCTURE; ENZYME ACTIVITY; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; SYNTHESIS;

ADENOSINE DEAMINASE; ANIMALS; CATTLE; ENZYME INHIBITORS; KINETICS; SPLEEN; STRUCTURE-ACTIVITY RELATIONSHIP;

ADA;

EID: 1542679128     PISSN: 15257770     EISSN: None     Source Type: Journal    
DOI: 10.1081/NCN-120027833     Document Type: Article

References (35)

1. Nakamura, H.; Koyama, G.; Iitaka, Y.; Ohno, M.; Yagisawa, N.; Kondo, S.; Maeda, K.; Umezawa, H. Structure of coformycin, an unusual nucleoside of microbial origin. J. Am. Chem. Soc. 1974, 96, 4327-4328.
2. Ohno, M.; Yagisawa, N.; Shibahara, S.; Kondo, S.; Maeda, K.; Umezawa, H. Synthesis of coformycin. J. Am. Chem. Soc. 1974, 96, 4326-4327.
3. Hawkins, L.D.; Hanvey, J.C.; Boyd, F.L., Jr.; Baker, D.C.; Showalter, H.D.H. Inhibitors of adenosine deaminase. Synthesis of coformycin and 3′-deoxycoformycin. Nucleosides Nucleotides 1983, 2, 479-494.
4. Woo, P.W.K.; Dion, H.W.; Lange, S.M.; Dahl, L.F.; Durham, L.J. A novel adenosine and ara-A deaminase inhibitor, (R)-3-(2-deoxy-β -D-erythropentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d]diazepin-8-ol. J. Heterocycl. Chem. 1974, 11, 641-643.
5. Baker, D.C.; Putt, S.R. A total synthesis of pentostatin, the potent inhibitor of adenosine deaminase. J. Am. Chem. Soc. 1979, 101, 6127-6128.
6. Chan, E.; Putt, S.R.; Showalter, H.D.H.; Baker, D.C. Total synthesis of (8R)-3-(2-deoxy-β-D-erythropentofuranosyl-3,6,7,8-tetrahydroimidazo[4,5-d] [1,3]diazepin-8-ol (Pentostatin), the potent inhibitor of adenosine deaminase. J. Org. Chem. 1982, 47, 3457-3464.
7. Van Truong, T.V.; Rapoport, H. Chirospecific synthesis of the tetrahydroimidazo-diazepinol aglycon of pentostatin and its analogues. J. Org. Chem. 1993, 58, 6090-6096.
8. Wolfenden, R.; Wentworth, D.F.; Mitchell, G.N. Influence of substituent ribose on transition state affinity in reactions catalyzed by adenosine deaminase. Biochemistry 1977, 16, 5071-5077.
9. Frick, L.; Wolfenden, R.; Amal, D.; Baker, D.C. Transition-state stabilization by adenosine deaminase: structural studies of its inhibitory complex with deoxycoformycin. Biochemistry 1986, 25, 1616-1621.
10. Kati, W.M.; Wolfenden, R. Contribution of a single hydroxyl group to transition-state discrimination by adenosine deaminase: evidence for an "entropy trap" mechanism. Biochemistry 1989, 28, 7919-7927.
11. Kurz, L.C.; Moix, L.; Riley, M.C.; Frieden, C. The rate of formation of transition-state analogs in the active site of adenosine deaminase is encounter-controlled: implications for the mechanism. Biochemistry 1992, 31, 39-48.
12. Agarwal, R.P.; Cha, S.; Crabtree, G.W.; Parks, R.E. Coformycin and deoxycoformycin: tight-binding inhibitors of adenosine deaminase. In Chemistry and Biology of Nucleosides and Nucleotides; Harmon, R.E., Robins, R.K., Townsend, L.B., Eds.; Academic Press: New York, 1978; 159-197.
13. Agarwal, R.P.; Spector, T.; Parks, R.E., Jr. Tight-binding inhibitors. IV. Inhibition of adenosine deaminases by various inhibitors. Biochem. Pharmacol. 1977, 26, 359-367.
14. Lum, C.T.; Sutherland, D.E.R.; Najarian, J.R. Inhibition for immunosuppression. N. Engl. J. Med. 1977, 296, 819.
15. Chassin, M.M.; Chirigos, M.A.; Johns, D.G.; Adamson, R.H. Adenosine deaminase inhibition for immunosuppression. N. Engl. J. Med. 1977, 296, 1232.
16. LePage, G.A.; Worth, L.S.; Kimball, A.P.C.R. 1481 Enhancement of the antitumor activity of arabinofuranosyladenine by 2′-deoxycoformycin. Cancer Res. 1976, 36, 1481.
17. Umezawa, H.; Tsutomu, S.; Yasuo, F.; Ikuyo, H.; Masaaki, I.; Tomio, T. Formycin and formycin B in cells of Ehrlich carcinoma and Escherichia coli. J. Antibiot. (Tokyo), Ser. A 1967, 20, 308-316.
18. Johns, D.G.; Adamson, R.H. Enhancement of the biological activity of cordycepin (3′-deoxyadenosine) by the adenosine deaminase inhibitor 2′-deoxycoformycin. Biochem. Pharmacol. 1976, 25, 1441.
19. Major, P.P.; Agarwal, R.P.; Kufe, D.W. Deoxycoformycin: neurological toxicity. Cancer Chemother. Pharmacol. 1981, 5, 193.
20. Major, P.P.; Agarwal, R.P.; Kufe, D.W. Clinical pharmacology of deoxycoformycin. Blood 1981, 58, 91.
21. Grever, M.; Miser, J.; Balcerzak, S.; Neidhart, J. The biochemical and clinical consequences of 2′-deoxycoformycin in refractory lymphoproliferative malignancy. Proc. Am. Assoc. Cancer Res. 1980, 21, 335.
22. Lambe, C.; Bugge, C.J.L.; Lafon, S.W.; Nelson, D.J.; Elion, G.B. Inhibition of adenosine deaminase (ADA) in vivo in CBA-J mice by erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) and its metabolic consequences. Fed. Proc. Am. Soc. Exp. Biol. 1979, 38, 670.
23. Acevedo, O.L.; Krawczyk, S.H.; Townsend, L.B. A novel approach towards the synthesis of the 3,4,5-trihydro-1,3-diazepin-5-ol ring structure. Tetrahedron Lett. 1983, 24, 4789-4792.
24. Acevedo, O.L.; Krawczyk, S.H.; Townsend, L.B. Synthesis of the new ring system, pyrazolo[3,4-d][1,3]diazepines. J. Heterocycl. Chem. 1985, 22, 349-352.
25. Acevedo, O.L.; Krawczyk, S.H.; Townsend, L.B. Total synthesis of (4R)- and (4S)-5,6-dihydro-1-β -D-ribofuranosyl-4H-pyrazolo[3,4-d][1,3]diazepin-4-ol and (8R)-and (8S)-7,8-dihydro-3-β-D-ribofuranosyl-6H-v-triazolo[4,5-d][1,3] diazepin-8-ol: two heterocyclic analogues of the nucleoside antibiotic coformycin. J. Org. Chem. 1986, 51, 1050-1058.
26. Hong, M.; Hosmane, R.S. Irreversible, tight-binding inhibition of adenosine deaminase by coformycins: inhibitor structural features that contribute to the mode of inhibition. Nucleosides Nucleotides 1997, 16, 1053-1057.
27. Hosmane, R.S.; Hong, M. How important is the N-3 sugar moiety in the tight-binding interaction of coformycin with adenosine deaminase? Biochem. Biophys. Res. Commun. 1997, 236, 88-93.
28. Wang, Z.; Quiocho, F.A. Complexes of adenosine deaminase with two potent inhibitors: x-ray structures in four independent molecules at pH of maximum activity. Biochemistry 1998, 37, 8314-8324.
29. Marrone, T.J.; Straatsma, T.P.; Briggs, J.M.; Wilson, D.K.; Quiocho, F.A.; McCammon, J.A. Theoretical study of inhibition of adenosine deaminase by (8R)-coformycin and (8R)-deoxycoformycin. J. Med. Chem. 1996, 39, 277.
30. Hosmane, R.S.; Lim, B.B. Chemistry of the 5:7-fused heteroaromatic systems: a novel rearrangement involving the imidazo[4,5-e][1,3,4]triazepine and pyrazolo [3,4-e][1,3,4]triazepine systems. Heterocycles 1988, 27, 31-34.
31. Hosmane, R.S.; Lim, B.B. A novel method for the synthesis of 6-(β-methyl)hydrazinopurine and 4-(β -methyl)hydrazinopyrazolo[3,4-d]pyrimidine. Synthesis 1988, 242-244.
32. Hosmane, R.S.; Lim, B.B.; Burnett, F.N. Rearrangements in heterocyclic synthesis: a novel translocation of an (N-amino-N-methyl)formamidine side-chain to the vinylogous nitrile function. J. Org. Chem. 1988, 53, 382-386.
33. Hosmane, R.S.; Lim, B.B.; Summers, M.F.; Siriwardane, U.; Hosmane, N.S.; Chu, S.C. Rearrangements in heterocyclic synthesis. 2. Novel transformations of 2-aminonicotino- and anthranilonitriles. J. Org. Chem. 1988, 53, 5309-5315.
34. Hosmane, R.S.; Bhadti, V.S.; Lim, B.B. Synthesis of a novel ring-expanded xanthine analogue and its several methyl or benzyl derivatives, containing the 5:7-fused imidazo[4,5-e][1,2,4]triazepine ring system. Synthesis 1990, 1095-1100.
35. Ostrowski, S. Synthesis of some new imidazole derivatives. Pol. J. Chem. 1994, 68, 2237-2247.